In contrast to 6MWD and N-terminal pro-brain natriuretic peptide (NT-proBNP), only cMRI variables demonstrated large STES, including in patients receiving background PAH therapy [13]. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.